HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2019, after the close of market on Thursday August 8, 2019.
The release will be accessible on Taro’s website at www.taro.com.
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.
Mariano Balaguer VP, Chief Financial Officer (914) 345-9001 Mariano.Balaguer@Taro.com
William J. Coote AVP, Business Finance, Treasurer and Investor Relations (914) 345-9001 William.Coote@Taro.com
Source: Taro Pharmaceutical Industries Ltd.